- Home
- FENC vs FEIM Comparison
FENC vs FEIM Comparison
Compare FENC & FEIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FENC
- FEIM
- Stock Information
- Founded
- FENC 1996
- FEIM 1961
- Country
- FENC United States
- FEIM United States
- Employees
- FENC N/A
- FEIM N/A
- Industry
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- FEIM Electrical Products
- Sector
- FENC Health Care
- FEIM Industrials
- Exchange
- FENC Nasdaq
- FEIM Nasdaq
- Market Cap
- FENC 156.9M
- FEIM 180.1M
- IPO Year
- FENC 2001
- FEIM N/A
- Fundamental
- Price
- FENC $5.95
- FEIM $17.35
- Analyst Decision
- FENC Strong Buy
- FEIM
- Analyst Count
- FENC 2
- FEIM 0
- Target Price
- FENC $14.00
- FEIM N/A
- AVG Volume (30 Days)
- FENC 50.4K
- FEIM 66.7K
- Earning Date
- FENC 05-20-2025
- FEIM 03-13-2025
- Dividend Yield
- FENC N/A
- FEIM 5.79%
- EPS Growth
- FENC N/A
- FEIM 604.98
- EPS
- FENC N/A
- FEIM 2.41
- Revenue
- FENC $47,538,000.00
- FEIM $65,400,999.00
- Revenue This Year
- FENC $2.68
- FEIM N/A
- Revenue Next Year
- FENC $71.63
- FEIM N/A
- P/E Ratio
- FENC N/A
- FEIM $7.02
- Revenue Growth
- FENC 123.69
- FEIM 24.10
- 52 Week Low
- FENC $3.96
- FEIM $8.62
- 52 Week High
- FENC $10.07
- FEIM $20.33
- Technical
- Relative Strength Index (RSI)
- FENC 51.33
- FEIM 50.49
- Support Level
- FENC $5.85
- FEIM $16.69
- Resistance Level
- FENC $6.61
- FEIM $18.25
- Average True Range (ATR)
- FENC 0.36
- FEIM 1.11
- MACD
- FENC 0.06
- FEIM -0.18
- Stochastic Oscillator
- FENC 54.20
- FEIM 23.49
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
About FEIM Frequency Electronics Inc.
Frequency Electronics Inc is engaged in the design, development, and manufacture of high-precision timing, and frequency control products for space, air, sea, and terrestrial applications. The company has FEI-NY and FEI-Zyfer reportable segments. It derives the majority of its revenues from the FEI-NY segment. FEI-NY segment operations consist principally of precision time and frequency control products used in three principal markets namely communication satellites (both commercial and U.S. Government-funded); terrestrial cellular telephone or other ground-based telecommunication stations; and other components and systems for the U.S. military.